RADNOR, Pa.--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX), an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, will be presenting at the Rodman & Renshaw Annual Global Investment Conference. The Conference will take place May 16 – 18, 2010 at the Grosvenor House Hotel in London, UK.
